EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,433,000 | – | 774,533 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $68,731,000 | 39.63% |
| CVI Holdings, LLC | 1,367,430 | $2,244,000 | 0.87% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 875,098 | $1,435,000 | 0.20% |
| BARD ASSOCIATES INC | 87,884 | $144,000 | 0.07% |
| HIGHLAND CAPITAL MANAGEMENT LP | 545,000 | $894,000 | 0.05% |
| HighTower Advisors, LLC | 5,284,738 | $8,667,000 | 0.05% |
| Kore Private Wealth LLC | 104,366 | $171,000 | 0.04% |
| Arcus Capital Partners, LLC | 25,000 | $41,000 | 0.02% |
| MOORE CAPITAL MANAGEMENT, LP | 320,000 | $525,000 | 0.01% |
| MATRIX ASSET ADVISORS INC/NY | 26,500 | $43,000 | 0.01% |